Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial

References

• Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002;13(4):589–598.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64(4):604–611.
   PubMed Web of Science ®Google Scholar
• Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006;24(30):4882–4887.
   PubMed Web of Science ®Google Scholar
• Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW. et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17 (Suppl 1):S112–S118.
   PubMedGoogle Scholar
• Gaab J, Rohleder N, Heitz V, Zhou JH, Shen WH, Johnson RW, Engert V, Schad T, Schürmeyer TH, et al. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology. 2005;30(2):188–198.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–1257.
   PubMed Web of Science ®Google Scholar
• Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, et al. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461–2478. doi:10.1007/s00520-015-2763-0.
   PubMed Web of Science ®Google Scholar
• Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun. 2012;26(6):830–848.
   PubMed Web of Science ®Google Scholar
• Mulligan AM, Raitman I, Feeley L, Pinnaduwage D, Nguyen, LT, O'Malley FP, et al. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry. Clin Cancer Res. 2013;19(2):336–346. doi:10.1158/1078-0432.CCR 11-3314.
   PubMed Web of Science ®Google Scholar
• Lunardi S, Lim SY, Muschel RJ, Brunner TB. IP-10/CXCL10 attracts regulatory T cells: implication for pancreatic cancer. OncoImmunology. 2015;4:e1027473. doi:10.1080/2162402X.2015.1027473
   PubMed Web of Science ®Google Scholar
• Lunardi S, Jamieson NB, Lim SY, Griffiths KL, Carvalho-Gaspar M, Al-Assar O et al. IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget. 2014;5:11064–11080. doi:10.18632/oncotarget.2519.
   PubMed Web of Science ®Google Scholar
• Fung FY, Li M, Breunis H, Timilshina N, Minden MD, Alibhai SM. Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia. Leuk Res. 2013;37:274–279. doi:10.1016/j.leukres.2012.11.013
   PubMed Web of Science ®Google Scholar
• Hamre H, Zeller B, Kanellopoulos A Ruud E, Fosså SD, Loge JH, et al. Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun. 2013;30:80–87. doi:10.1016/j.bbi. 2013.01.006.
   PubMed Web of Science ®Google Scholar
• Prinsen H, Bleijenberg G, Zwarts MJ, Hopman MT, Heerschap A, van Laarhoven HW. Physiological and neurophysiological determinants of postcancer fatigue: design of a randomized controlled trial. BMC Cancer. 2012;12:256.
   PubMed Web of Science ®Google Scholar
• Prinsen H, Heerschap A, Bleijenberg G, Zwarts MJ, Leer JW, van Asten JJ. et al. Magnetic resonance spectroscopic imaging and volumetric measurements of the brain in patients with postcancer fatigue: a randomized controlled trial. PLoS One. 2013;8(9):e74638.
   PubMed Web of Science ®Google Scholar
• Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer. 2007;97(5):612–618.
   PubMed Web of Science ®Google Scholar
• Servaes P, Verhagen S, Schreuder HW, Veth RP, Bleijenberg G. Fatigue after treatment for malignant and benign bone and soft tissue tumors. J Pain Symptom Manage. 2003;26(6):1113–22.
   PubMed Web of Science ®Google Scholar
• Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38(1):27–43.
   PubMed Web of Science ®Google Scholar
• Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–170.
   PubMed Web of Science ®Google Scholar
• Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38(5):383–392.
   PubMed Web of Science ®Google Scholar
• Bartsch HH, Weis J, Moser MT. Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors. Onkologie. 2003;26(1): 51–57.
   PubMedGoogle Scholar
• Dimeo F, Schmittel A, Fietz T, Schwartz S, Köhler P, Böning D. et al. Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol. 2004;15(8):1237–1242.
   PubMed Web of Science ®Google Scholar
• Gielissen MF, Schattenberg AV, Verhagen CA, Rinkes MJ, Bremmers ME, Bleijenberg G. Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant. 2007;39(10):595–603.
   PubMed Web of Science ®Google Scholar
• Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M. et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000;19(1):5–14.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–753.
   PubMed Web of Science ®Google Scholar
• Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998;25(5):915–920.
   PubMedGoogle Scholar